Barclays

Barclays’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Barclays’s Portfolio KNTE Stock Details KNTE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$38K	Sell
2023 Q4	$35K	Hold
2023 Q3	$21K	Hold
2023 Q2	$44K	Sell
2023 Q1	$183K	Buy
2022 Q4	$149K	Buy
2022 Q3	$185K	Sell
2022 Q2	$197K	Buy